Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ardelyx Inc (NASDAQ: ARDX)

 
ARDX Technical Analysis
5
As on 9th Jun 2023 ARDX STOCK Price closed @ 3.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.97 & Strong Buy for SHORT-TERM with Stoploss of 0.89 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARDXSTOCK Price

Open 3.95 Change Price %
High 4.03 1 Day 0.05 1.27
Low 3.88 1 Week 0.64 19.16
Close 3.98 1 Month -0.54 -11.95
Volume 4596600 1 Year 2.74 220.97
52 Week High 4.95 | 52 Week Low 0.51
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ARDX
Daily Charts		 ARDX
Intraday Charts		 Whats New @
Bazaartrend		 ARDX
Free Analysis
 
ARDX Important Levels Intraday
RESISTANCE4.27
RESISTANCE4.18
RESISTANCE4.12
RESISTANCE4.06
SUPPORT3.90
SUPPORT3.84
SUPPORT3.78
SUPPORT3.69
 
ARDX Forecast May 2024
Share
4th UP Forecast4.69
3rd UP Forecast4.46
2nd UP Forecast4.32
1st UP Forecast4.18
1st DOWN Forecast3.78
2nd DOWN Forecast3.64
3rd DOWN Forecast3.5
4th DOWN Forecast3.27
 
ARDX Weekly Forecast
4th UP Forecast4.44
3rd UP Forecast4.29
2nd UP Forecast4.20
1st UP Forecast4.11
1st DOWN Forecast3.85
2nd DOWN Forecast3.76
3rd DOWN Forecast3.67
4th DOWN Forecast3.52
 
ARDX Forecast2024
4th UP Forecast12.9
3rd UP Forecast10.04
2nd UP Forecast8.27
1st UP Forecast6.5
1st DOWN Forecast1.46
2nd DOWN Forecast-0.31
3rd DOWN Forecast-2.08
4th DOWN Forecast-4.94
 
 
ARDX Other Details
Segment EQ
Market Capital 124773992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ARDX Address
ARDX
 
ARDX Latest News
 
Your Comments and Response on Ardelyx Inc
 
ARDX Business Profile
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California. Address: 34175 Ardenwood Boulevard, Fremont, CA, United States, 94555
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service